TTP

TTP is a medical device development consultancy that creates respiratory, parenteral, and local and targeted solutions. Its expertise spans device engineering, scientific innovation, and patient-centric design.

Headquarters
TTP PLC
TTP Campus
Cambridge Road
Melbourn
SG8 6HQ
United Kingdom

Phone / Contact

T: +44 1763 262626

TTP is a medical device development consultancy that creates respiratory, parenteral, and local and targeted solutions. Its expertise spans device engineering, scientific innovation, and patient-centric design, and its team has developed more than 35 advanced drug delivery systems.

TTP’s capabilities deliver scalable, efficient, and effective solutions tailored to meet complex industry challenges.

The company was founded in 1987.

Articles by TTP

RETHINKING GLP-1 DELIVERY DEVICES: DESIGNING FOR USERS BEYOND DIABETES

Dan Lock explores how the experiences and motivations of individuals using glucagon-like peptide 1 drugs for weight loss may differ from those managing diabetes or heart disease.

SCALING GLP-1 DRUGS WITHOUT A MOUNTAIN OF WASTE

Matt Parker, Simon Lyons and Alex Lyness, look at how the continued success of glucagon-like peptide-1 drugs is bringing into focus the need for environmentally sustainable self-injection systems. They discuss whether reloadable autoinjectors could be the way to boost sustainability, lower cost per dose, and match the scale and rate of adoption of these new therapies.

DIRECTIONS FOR WEARABLE ON-BODY INJECTOR SYSTEMS AND BEYOND

Matt Parker, Karthik Chellappan and David Cottenden discuss the current state of play for large-volume injection and look into the challenges that on-body delivery systems currently in development will need to overcome to find success in a changing marketplace.

THE IRONIES OF AUTOMATION: LESSONS FOR REMOTE PATIENT MONITORING

Dan Lock considers how to overcome potential pitfalls and make the most of remote patient monitoring for the benefit of both patient care and clinical trials.

Dr Nathan Wilkinson

BEYOND THE EYEDROPPER BOTTLE – THREE WAYS TO IMPROVE ADHERENCE

Nathan Wilkinson, Catherine Wyman and Matt Parker discuss the future outlook of ophthalmic drug delivery beyond the traditional eyedropper bottle, including new delivery technologies, sustained-release therapeutics and digital healthcare applications.

Top